Voyager Therapeutics
VYGR
43 hedge funds and large institutions have $86.5M invested in Voyager Therapeutics in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and closing their positions.
23% more funds holding
Funds holding: 35 → 43 (+8)
8% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 13
62% less capital invested
Capital invested by funds: $225M → $86.5M (-$139M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
+$1.16M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.13M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$567K |
| 4 |
GC
Globeflex Capital
San Diego,
California
|
+$456K |
| 5 |
State Street
Boston,
Massachusetts
|
+$135K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.86M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$1.57M |
| 3 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$370K |
| 4 |
Goldman Sachs
New York
|
-$199K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$88.7K |
VYGR Hedge Fund Activity: Q1 2016 in Review
43 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q1 2016, worth a combined $86.5M — down 62% from $225M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new VYGR positions and 0 closed out — a net gain of 8 holders — while 14 added to existing stakes and 13 trimmed.
The largest buyer was Casdin Capital, adding an estimated $1.16M. The largest seller was Wellington Management Group, cutting an estimated $5.86M.
- 43 institutional investors held Voyager Therapeutics (VYGR) as of Q1 2016, up from 35 in Q4 2015.
- Funds reported $86.5M of Voyager Therapeutics stock for Q1 2016, down 62% quarter-over-quarter.
- 8 funds opened new Voyager Therapeutics positions in Q1 2016 and 0 closed out, a net change of +8 holders.
- The largest Voyager Therapeutics buyer in Q1 2016 was Casdin Capital, an estimated $1.16M added.
- The largest Voyager Therapeutics seller in Q1 2016 was Wellington Management Group, an estimated $5.86M sold.
Based on aggregated 13F filings for Q1 2016.